In a recent study, CD4+ T-cell clones were traced via paired scRNA/TCR-seq across tumors, tumor-adjacent normal tissues, lymph nodes, and peripheral blood from NSCLC patients treated with ICB [134]. The gene discussed is CD4; the disease is neoplasm.